Bloomberg—How big is the coronavirus outbreak? A lot bigger than we were initially told, it turns out. On Thursday, confirmed cases of Covid-19 in China’s Hubei Province—the epidemic’s epicenter—jumped by almost 15,000. It’s not that there was a sudden wave of new infections. Rather, the increase reflects a change in how China counts patients; it… Read More »
By Clare Wilson US teens aren’t that in to vapingeldar nurkovic/Alamy “How Juul hooked a generation on nicotine” was a New York Times headline from 2018 on the new addiction apparently sweeping the youth of the US. It wasn’t the only media outlet to cover the rise in e-cigarettes, as a US government survey from… Read More »
(Reuters) – Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing. The company was hoping to win its first approval for the therapy, RVT-802, aimed at treating congenital athymia, a disorder affecting… Read More »
AMSTERDAM – Two major Dutch hospitals say they will stop importing human body parts from American firms, which they have been doing without any regulation for a decade. Outside view of Erasmus MC Medical Center in Rotterdam, Netherlands December 8, 2018. REUTERS/Eva Plevier The hospitals told Reuters in recent weeks they made their decisions on ethical grounds.… Read More »
Dive Brief: Roughly one in five Medicare patients in long-term care hospitals experienced adverse events, and another 25% experienced temporary harmful events, according to a new report by the HHS Office of Inspector General (OIG). More than half (53%) of the adverse events patients suffered caused F level harm, meaning they prolonged the LTCH stay, became… Read More »